St. Jude Medical, a device maker headquartered in St. Paul, Minn., launched new SyncAV cardiac resynchronization therapy software to treat heart failure in patients who do not respond to conventional treatments.
The new software works in conjunction with the company's MultiPoint Pacing technology to automatically adjust the heart's pacing based on real time changes in a patient's cardiac condition.
While studies show that traditional CRT technology can improve the quality of life for some of the 23 million people globally living with congestive heart failure, not all patients respond to this conventional treatment.
St. Jude Medical's SyncAV CRT technology now provides additional options for physicians and patients to maximize the beneficial effect of CRT.
"The SyncAV CRT algorithm dynamically individualizes programming to work towards providing patients with the right settings at the right time helping offer the best possible outcome for even our most complex patients. Our goal is to utilize the technology to improve outcomes while offering patients who do not respond to therapy with additional options for treatment," said Timothy Betts, MD, consultant cardiologist and electrophysiologist at John Radcliffe Hospital in Oxford, England.
More articles on supply chain:
VA teams with Underwriters Laboratories to address medical device cybersecurity
FDA approves new catheterization device
Anthem expands member access to HIV/AIDS medications